Tenax Therapeutics appoints Thomas A. McGauley as Interim CFO, effective Dec 2, 2024

TENAX THERAPEUTICS, INC.

Thomas A. McGauley appointed Interim CFO and principal financial/accounting officer, replacing Lawrence R. Hoffman.
McGauley provides services through Danforth Advisors at $410 per hour with up to 4% annual increase.
McGauley has 25+ years financial experience, including interim CFO at Galectin Therapeutics and manager at PwC.
He holds a CPA and B.S.B.A in Accounting from Stonehill College; no familial relationships with officers or directors.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.